Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Helix Energy Solutions
HLX
$1.34B
| $1.96M | ﹤0.01% |
252,227
-4,700
| -2% | -$37.8K |
|
|
KDNY
2252
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.96M | ﹤0.01% |
36,380
+32,160
| +762% | +$1.82M |
|
2253
Cadiz
CDZI
$251M
| $1.94M | ﹤0.01% |
129,200
-138,200
| -52% | -$1.93M |
|
|
SMC
2254
Summit Midstream
SMC
$420M
| $1.94M | ﹤0.01% |
5,395
-7,093
| -57% | -$2.57M |
|
|
ACFC
2255
DELISTED
Atlantic Coast Financial Corporation
ACFC
| $1.94M | ﹤0.01% |
254,300
+15,200
| +6% | +$115K |
|
|
SPRT
2256
DELISTED
support.com, Inc.
SPRT
| $1.94M | ﹤0.01% |
882,463
+77,230
| +10% | +$173K |
|
|
ARI
2257
Apollo Commercial Real Estate
ARI
$864M
| $1.94M | ﹤0.01% |
+102,940
| New | +$1.83M |
|
2258
First Mid Bancshares
FMBH
$1.4B
| $1.94M | ﹤0.01% |
57,200
-13,400
| -19% | -$437K |
|
2259
Myers Industries
MYE
$1.24B
| $1.94M | ﹤0.01% |
122,100
+8,000
| +7% | +$114K |
|
|
RMP
2260
DELISTED
Rice Midstream Partners LP
RMP
| $1.94M | ﹤0.01% |
76,733
-75,726
| -50% | -$1.86M |
|
2261
The RMR Group
RMR
$335M
| $1.93M | ﹤0.01% |
39,000
-34,800
| -47% | -$1.65M |
|
2262
V2X
VVX
$2.7B
| $1.93M | ﹤0.01% |
86,400
+42,400
| +96% | +$973K |
|
2263
Insight Enterprises
NSIT
$3.85B
| $1.93M | ﹤0.01% |
+46,973
| New | +$1.92M |
|
|
HIL
2264
DELISTED
Hill International, Inc. Common Stock
HIL
| $1.93M | ﹤0.01% |
464,400
+1,800
| +0.4% | +$8.95K |
|
2265
iShares MSCI Mexico ETF
EWW
$1.89B
| $1.92M | ﹤0.01% |
+37,600
| New | +$1.74M |
|
2266
Peoples Financial Services
PFIS
$718M
| $1.92M | ﹤0.01% |
46,000
+200
| +0.4% | +$8.71K |
|
|
WBA
2267
DELISTED
Walgreens Boots Alliance
WBA
| $1.92M | ﹤0.01% |
23,100
-1,905,200
| -99% | -$160M |
|
2268
Pluri
PLUR
$17M
| $1.91M | ﹤0.01% |
19,423
+1,613
| +9% | +$158K |
|
|
NSH
2269
DELISTED
NuStar GP Holdings LLC
NSH
| $1.91M | ﹤0.01% |
68,300
+38,136
| +126% | +$1.13M |
|
2270
Daktronics
DAKT
$946M
| $1.9M | ﹤0.01% |
201,300
+78,500
| +64% | +$774K |
|
|
PFNX
2271
DELISTED
Pfenex Inc.
PFNX
| $1.89M | ﹤0.01% |
325,800
+194,700
| +149% | +$1.46M |
|
2272
CONMED
CNMD
$1.3B
| $1.89M | ﹤0.01% |
+42,481
| New | +$1.83M |
|
|
DWCH
2273
DELISTED
Datawatch Corp
DWCH
| $1.89M | ﹤0.01% |
224,600
+57,200
| +34% | +$409K |
|
2274
AMERISAFE
AMSF
$562M
| $1.88M | ﹤0.01% |
28,900
-10,500
| -27% | -$675K |
|
2275
Cumberland Pharmaceuticals
CPIX
$99.8M
| $1.88M | ﹤0.01% |
270,240
+13,240
| +5% | +$80.3K |
|
Similar funds
Renaissance Technologies's Q1 2017 Portfolio in Review
As of Q1 2017, Renaissance Technologies held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Renaissance Technologies's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Renaissance Technologies added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Renaissance Technologies's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Renaissance Technologies fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Renaissance Technologies opened 433 new positions and closed 462 in Q1 2017.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.